dr. pemmaraju on the challenges of targeting tp53 mutations in mds/aml
Published 4 years ago • 318 plays • Length 1:56Download video MP4
Download video MP3
Similar videos
-
2:24
the challenges of treating tp53-mutated aml and mds
-
1:57
dr. cluzeau on the efficacy of apr-246/azacitidine in tp53-mutated mds and aml
-
1:53
challenges in treating patients with tp53-mutated aml and future outlooks
-
1:08
novel strategies to target p53-mutant hematological malignancies
-
1:51
dr. pemmaraju on methods to treat anemia in mpns
-
2:13
dr. rule on patients with p53-mutated mcl
-
1:23
immunological impact of tp53 in mds
-
1:25
trial to evaluate eprenetapopt-azacytidine combo in tp53 mds completes enrollment
-
2:42
challenges in treating patients with tp53-mutated mcl & promising novel therapies being explored
-
1:24
dr. pemmaraju on the trial of sl-401 in blastic plasmacytoid dendritic cell neoplasms
-
5:18
risk stratification of myelodysplastic syndromes and acute myeloid leukemia
-
1:10
dr. meeks on the importance of p53 and rb1 in bladder cancer
-
1:15
dr. rule on treatment approaches for patients with p53-mutated mcl
-
0:41
dr. dinardo on the fda approval of oral azacitidine in aml
-
3:40
hypomethylating agents for aml
-
1:36
the impact of tp53 mutations in patients with myelofibrosis undergoing sct
-
1:40:03
mena forum on myelodysplastic syndrome challenges
-
7:33
testing for flt3 mutations in the community setting of aml
-
2:15
dr. daver on the utility of maintenance therapy in aml